2006
DOI: 10.1016/j.addr.2006.01.003
|View full text |Cite
|
Sign up to set email alerts
|

Tight junction modulation and its relationship to drug delivery☆

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
96
1
2

Year Published

2007
2007
2013
2013

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 303 publications
(101 citation statements)
references
References 89 publications
1
96
1
2
Order By: Relevance
“…2C) strongly indicates that ANG-I enters zebrafish in which it is converted to ANG-II. Rather than transcellularly, ANG may enter larvae via tight junctions (Salama et al 2006). The dosage of ANG used in this study was higher than in previous studies, in which isolated kidney segments were infused with ANG-II (1-100 nM; Houillier et al 1996, Rothenberger et al 2007; the requirement for higher levels in this study may reflect the reduced permeability of ANG into larval zebrafish.…”
Section: Discussioncontrasting
confidence: 38%
“…2C) strongly indicates that ANG-I enters zebrafish in which it is converted to ANG-II. Rather than transcellularly, ANG may enter larvae via tight junctions (Salama et al 2006). The dosage of ANG used in this study was higher than in previous studies, in which isolated kidney segments were infused with ANG-II (1-100 nM; Houillier et al 1996, Rothenberger et al 2007; the requirement for higher levels in this study may reflect the reduced permeability of ANG into larval zebrafish.…”
Section: Discussioncontrasting
confidence: 38%
“…FD-4, a hydrophilic and high-molecular-weight drug, would permeate through a paracellular pathway by passive diffusion. 14 2 ). Corneal TEER in the present study is consistent with this report.…”
Section: Resultsmentioning
confidence: 99%
“…These include the use of influx transporters, blocking of efflux transporters, or receptor-mediated endocytosis (2). Alternative approaches aim to enhance paracellular permeation of drugs by loosening the TJ (3,4). This strategy has the advantage that it could improve the delivery of structurally unrelated drugs, and the drug itself does not have to be modified.…”
mentioning
confidence: 99%